14,463 results on '"anemia, aplastic"'
Search Results
52. Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
53. Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant
54. A Study of Romiplostim for the Treatment of Refractory Transfusion-dependent NSAA
55. TPO-Mimetic Use in Children for Hematopoietic Failure
56. Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAA
57. NAC for Hematopoietic Recovery in SAA
58. Ropustin for Refractory Aplastic Anaemia After Radiotherapy - a Single-centre, Prospective, Open-label, Single-arm Study
59. Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia (BMT CTN CureAA)
60. Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia
61. Outcomes in Bone Marrow Aplasia.
62. Effects of Levetiracetam Monotherapy on Various Hematological Parameters in Adult Patients Suffering of Epilepsy
63. TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
64. Fludarabine Based RIC for Bone Marrow Failure Syndromes
65. Unrelated And Partially Matched Related Donor PSCT w/ T Cell Receptor (TCR) αβ Depletion for Patients With BMF
66. MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
67. Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
68. CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation
69. Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
70. A Study of Emapalumab for Pediatric Aplastic Anemia
71. A Prospective Study on the Treatment of Recurrent/Refractory/Intolerable NSAA With Lusutrombopag
72. Luspatercept Plus CsA vs CsA for the Treatment of Newly Diagnosed Non-Transfusion-Dependent NSAA
73. A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia
74. Clinical Study on Modified Allogeneic Hematopoietic Stem Cell Transplantation Regimen for Severe Aplastic Anemia
75. Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
76. Total Body Irradiation Treatments for Patients Treated at European Institute of Oncology
77. Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia
78. Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
79. Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to Calcineurin Inhibitors
80. Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF) (SAA-G-CSF)
81. Efficacy and Safety of Avatrombopag vs. Avatrombopag Combined With rhTPO in the Treatment of SAA
82. Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness
83. RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs) (RADeep)
84. Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization
85. Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the Elderly
86. A Bioequivalence Study of Hetrombopag in Healthy Subjects
87. Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure Disorders
88. Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression (HAPLO-EMPTY)
89. The Optimization of Conditioning Regimen for HLA Matched HSCT in SAA
90. Study to Assess the Safety and Efficacy of Eltrombopag in Chinese Refractory or Relapsed Severe Aplastic Anemia (SAA) Subjects.
91. Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia
92. AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
93. Conditioning Regimen Containing Low Dose ATG for The Treatment of Acquired SAA Receiving sUCBT
94. Autologous Tregs for Aplastic Anaemia (TIARA)
95. Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive Therapy
96. Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study
97. Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant
98. Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia (RATGAA07)
99. Safety and Effectiveness of Trappa Ethanolamine Tablets Combined With Ciclosporin in the Treatment of Primary Treatment of Non-severe Aplastic Anemia
100. Nandrolone Decanoate in the Treatment of Telomeropathies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.